Northern Trust’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.8K | Buy |
111,660
+19,120
| +21% | +$10.1K | ﹤0.01% | 4288 |
|
|
2026
Q1 | $52.4K | Hold |
92,540
| – | – | ﹤0.01% | 4236 |
|
|
2025
Q4 | $59.2K | Buy |
92,540
+980
| +1% | +$754 | ﹤0.01% | 4246 |
|
|
2025
Q3 | $85.5K | Hold |
91,560
| – | – | ﹤0.01% | 4174 |
|
|
2025
Q2 | $117K | Hold |
91,560
| – | – | ﹤0.01% | 4080 |
|
|
2025
Q1 | $91.6K | Hold |
91,560
| – | – | ﹤0.01% | 4135 |
|
|
2024
Q4 | $83.3K | Buy |
91,560
+16,701
| +22% | +$16.4K | ﹤0.01% | 4190 |
|
|
2024
Q3 | $112K | Sell |
74,859
-2
| -0% | -$2 | ﹤0.01% | 4022 |
|
|
2024
Q2 | $52.6K | Sell |
74,861
-152
| -0.2% | -$132 | ﹤0.01% | 4202 |
|
|
2024
Q1 | $71.3K | Hold |
75,013
| – | – | ﹤0.01% | 4165 |
|
|
2023
Q4 | $83.3K | Sell |
75,013
-2
| -0% | -$3 | ﹤0.01% | 4150 |
|
|
2023
Q3 | $141K | Hold |
75,015
| – | – | ﹤0.01% | 3925 |
|
|
2023
Q2 | $269K | Buy |
75,015
+1,347
| +2% | +$4.26K | ﹤0.01% | 3713 |
|
|
2023
Q1 | $248K | Buy |
73,668
+2,335
| +3% | +$7.01K | ﹤0.01% | 3759 |
|
|
2022
Q4 | $111K | Hold |
71,333
| – | – | ﹤0.01% | 4061 |
|
|
2022
Q3 | $97K | Sell |
71,333
-250
| -0.3% | -$488 | ﹤0.01% | 4121 |
|
|
2022
Q2 | $157K | Sell |
71,583
-290,811
| -80% | -$668K | ﹤0.01% | 4010 |
|
|
2022
Q1 | $1.16M | Sell |
362,394
-16,858
| -4% | -$60.4K | ﹤0.01% | 3358 |
|
|
2021
Q4 | $1.59M | Sell |
379,252
-3,229
| -0.8% | -$18.1K | ﹤0.01% | 3337 |
|
|
2021
Q3 | $3.11M | Sell |
382,481
-23,130
| -6% | -$188K | ﹤0.01% | 3040 |
|
|
2021
Q2 | $3.06M | Sell |
405,611
-21,397
| -5% | -$180K | ﹤0.01% | 3138 |
|
|
2021
Q1 | $3.71M | Sell |
427,008
-30,117
| -7% | -$287K | ﹤0.01% | 2926 |
|
|
2020
Q4 | $3.64M | Buy |
457,125
+1,963
| +0.4% | +$16.4K | ﹤0.01% | 2856 |
|
|
2020
Q3 | $3.63M | Buy |
455,162
+95,897
| +27% | +$865K | ﹤0.01% | 2734 |
|
|
2020
Q2 | $3.56M | Buy |
359,265
+10,364
| +3% | +$95.2K | ﹤0.01% | 2729 |
|
|
2020
Q1 | $2.7M | Sell |
348,901
-13,850
| -4% | -$69.9K | ﹤0.01% | 2679 |
|
|
2019
Q4 | $1.4M | Sell |
362,751
-3,059
| -0.8% | -$13.3K | ﹤0.01% | 3288 |
|
|
2019
Q3 | $1.84M | Buy |
365,810
+11,363
| +3% | +$66.1K | ﹤0.01% | 3144 |
|
|
2019
Q2 | $2.34M | Buy |
354,447
+5,852
| +2% | +$40.2K | ﹤0.01% | 2993 |
|
|
2019
Q1 | $2.64M | Sell |
348,595
-4,581
| -1% | -$35.7K | ﹤0.01% | 2908 |
|
|
2018
Q4 | $2.85M | Sell |
353,176
-7,640
| -2% | -$75.9K | ﹤0.01% | 2853 |
|
|
2018
Q3 | $4.66M | Buy |
360,816
+51,548
| +17% | +$646K | ﹤0.01% | 2721 |
|
|
2018
Q2 | $3.53M | Buy |
309,268
+261,154
| +543% | +$2.47M | ﹤0.01% | 2883 |
|
|
2018
Q1 | $339K | Hold |
48,114
| – | – | ﹤0.01% | 3673 |
|
|
2017
Q4 | $313K | Sell |
48,114
-651
| -1% | -$4.14K | ﹤0.01% | 3674 |
|
|
2017
Q3 | $302K | Buy |
48,765
+11,925
| +32% | +$60.8K | ﹤0.01% | 3674 |
|
|
2017
Q2 | $158K | Hold |
36,840
| – | – | ﹤0.01% | 3871 |
|
|
2017
Q1 | $166K | Buy |
36,840
+12,266
| +50% | +$68.5K | ﹤0.01% | 3838 |
|
|
2016
Q4 | $134K | Buy |
24,574
+865
| +4% | +$4.74K | ﹤0.01% | 3837 |
|
|
2016
Q3 | $152K | Hold |
23,709
| – | – | ﹤0.01% | 3803 |
|
|
2016
Q2 | $108K | Hold |
23,709
| – | – | ﹤0.01% | 3872 |
|
|
2016
Q1 | $93K | Hold |
23,709
| – | – | ﹤0.01% | 3920 |
|
|
2015
Q4 | $132K | Hold |
23,709
| – | – | ﹤0.01% | 3871 |
|
|
2015
Q3 | $150K | Buy |
23,709
+4,167
| +21% | +$27.8K | ﹤0.01% | 3828 |
|
|
2015
Q2 | $120K | Buy |
19,542
+4,458
| +30% | +$30.3K | ﹤0.01% | 3912 |
|
|
2015
Q1 | $199K | Buy |
+15,084
| New | +$155K | ﹤0.01% | 3873 |
|
Other funds holding CTSO
AC
VCM
CM
SC
SIG
VFT
Northern Trust's CTSO Position: Q2 2026 in Review
Northern Trust increased its Cytosorbents Corp (CTSO) stake by 21% in Q2 2026, buying an estimated $10.1K and bringing the position to 111,660 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4288.
Northern Trust first reported a position in CTSO in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.66M in Q3 2018. 42 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.
- Northern Trust held 111,660 shares of Cytosorbents Corp worth $41.8K as of Q2 2026.
- Northern Trust bought 19,120 Cytosorbents Corp shares in Q2 2026, an estimated $10.1K.
- Cytosorbents Corp made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4288 holding.
- Northern Trust first reported a position in Cytosorbents Corp in Q1 2015 and has held it in 46 quarters since.
- Northern Trust's Cytosorbents Corp position peaked at $4.66M in Q3 2018.
- 42 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.